<![CDATA[全球財經專業評論]]> observerbio Mon, 28 Oct 2024 22:59:01 +0800 Copyright PChome Online. All Rights Reserved Mypaper Blog zh PChome新聞台Blog img/channel-ttimes.gif <![CDATA[美生技商AiBtl整併馬來西亞國際生醫領導品牌BioLive,預計2025上半年那斯達克掛牌]]> observerbio/post/1381964094 observerbio/post/1381964094 Tue, 15 Apr 2025 08:00:00 +0800 observerbio/post/1381964094#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381964094"><BR>原文連結:https://vocus.cc/article/67ed0401fd8978000130a9b...<BR><a href="observerbio/post/1381964094" target="_blank">...繼續閱讀</a> <![CDATA[企業經營兩樣情,基因檢測公司申請破產,高階新藥醫材開發集團迎來大幅成長]]> observerbio/post/1381963603 observerbio/post/1381963603 Sat, 12 Apr 2025 08:00:00 +0800 observerbio/post/1381963603#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381963603"><BR>原文連結:https://vocus.cc/article/67e95845fd8978000136756...<BR><a href="observerbio/post/1381963603" target="_blank">...繼續閱讀</a> <![CDATA[加拿大資本市場資金豐沛,將成為全球產業IPO的最佳去處,OncoX有望成為新科上市企業]]> observerbio/post/1381962861 observerbio/post/1381962861 Thu, 10 Apr 2025 08:00:00 +0800 observerbio/post/1381962861#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381962861"><BR>加拿大企業IPO崛起,美國政策下的投資新契機,OncoX有望成為新科上市公司 原文連結:https://v...<BR><a href="observerbio/post/1381962861" target="_blank">...繼續閱讀</a> <![CDATA[華爾街專訪ABVC BioPharma執行長,2025里程碑:「預期至少獲得1000萬美元的收入」]]> observerbio/post/1381962352 observerbio/post/1381962352 Wed, 09 Apr 2025 08:00:00 +0800 observerbio/post/1381962352#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381962352"><BR>華爾街記者採訪ABVC BioPharma(納斯達克股票代碼:ABVC)執行長Uttam Patil,重點...<BR><a href="observerbio/post/1381962352" target="_blank">...繼續閱讀</a> <![CDATA[《前瞻醫療專題二》產學研合作帶動產業跨領域整併,加拿大生技商OncoX成為模範]]> observerbio/post/1381961923 observerbio/post/1381961923 Tue, 08 Apr 2025 08:00:00 +0800 observerbio/post/1381961923#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381961923"><BR>原文連結:https://vocus.cc/article/67d2e4e8fd89780001f9937...<BR><a href="observerbio/post/1381961923" target="_blank">...繼續閱讀</a> <![CDATA[AiBtl藥業平凡啟程偉大開局,ABVC集團母以子貴,預期創造龐大市值溢價空間]]> observerbio/post/1381961921 observerbio/post/1381961921 Tue, 08 Apr 2025 08:00:00 +0800 observerbio/post/1381961921#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381961921"><BR>原文連結:https://vocus.cc/article/67d0f8a0fd89780001b0134...<BR><a href="observerbio/post/1381961921" target="_blank">...繼續閱讀</a> <![CDATA[哪吒動畫風靡全球,反思生技產業的靈珠與魔丸]]> observerbio/post/1381961459 observerbio/post/1381961459 Mon, 07 Apr 2025 08:00:00 +0800 observerbio/post/1381961459#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381961459"><BR>原文連結:https://vocus.cc/article/67bd0e57fd89780001cfd24...<BR><a href="observerbio/post/1381961459" target="_blank">...繼續閱讀</a> <![CDATA[羅氏藥廠授權生產血癌用藥爆缺貨!台廠藥華藥受惠,加拿大生技商OncoX加速植物型新藥開發進程]]> observerbio/post/1381960677 observerbio/post/1381960677 Sun, 06 Apr 2025 08:00:00 +0800 observerbio/post/1381960677#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381960677"><BR>原文出處:https://vocus.cc/article/67b2c4a8fd89780001e52e1...<BR><a href="observerbio/post/1381960677" target="_blank">...繼續閱讀</a> <![CDATA[《企業IPO專題一》生技產業掛牌萬眾矚目,2025年美生技商AiBtl拔頭籌]]> observerbio/post/1381959313 observerbio/post/1381959313 Sat, 05 Apr 2025 08:00:00 +0800 observerbio/post/1381959313#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381959313"><BR>原文出處:https://vocus.cc/article/67ade61efd89780001b8509...<BR><a href="observerbio/post/1381959313" target="_blank">...繼續閱讀</a> <![CDATA[《企業IPO專題二》美國生技商AiBtl四大優勢,那斯達克掛牌上市穩!]]> observerbio/post/1381959314 observerbio/post/1381959314 Sat, 05 Apr 2025 08:00:00 +0800 observerbio/post/1381959314#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381959314"><BR>原文出處:https://vocus.cc/article/67ae9fcffd89780001dbfd0...<BR><a href="observerbio/post/1381959314" target="_blank">...繼續閱讀</a> <![CDATA[輝達黃仁勳:生命工程年代即將到來!新創癌藥企業OncoX擁專利,2025年揮軍加拿大金融市場]]> observerbio/post/1381958760 observerbio/post/1381958760 Fri, 04 Apr 2025 08:00:00 +0800 observerbio/post/1381958760#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381958760"><BR>專業新創癌藥企業OncoX擁植物新藥、生醫產品研發專利,2025年揮軍加拿大金融市場 原文連結: http...<BR><a href="observerbio/post/1381958760" target="_blank">...繼續閱讀</a> <![CDATA[ABVC集團萬箭齊發,準上市子公司AiBtl藥業併購大馬生醫營銷新星BioLive]]> observerbio/post/1381958491 observerbio/post/1381958491 Thu, 03 Apr 2025 18:25:45 +0800 observerbio/post/1381958491#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381958491"><BR>原文連結:https://vocus.cc/article/6794d5bbfd8978000114685...<BR><a href="observerbio/post/1381958491" target="_blank">...繼續閱讀</a> <![CDATA[BioLive國際團隊醫學新藍海,加入美國準上市生技公司AiBtl藥業,共創千萬美元產值]]> observerbio/post/1381958490 observerbio/post/1381958490 Thu, 03 Apr 2025 18:23:46 +0800 observerbio/post/1381958490#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381958490"><BR>原文連結:https://vocus.cc/article/679356f6fd89780001dafaf...<BR><a href="observerbio/post/1381958490" target="_blank">...繼續閱讀</a> <![CDATA[ABVC BioPharma和AiBtl BioPharma的全球商業開發團隊參加第43屆摩根大通醫療保健年度會議]]> observerbio/post/1381958483 observerbio/post/1381958483 Thu, 03 Apr 2025 18:15:28 +0800 observerbio/post/1381958483#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381958483"><BR>加州弗里蒙特-2025年1月16日(NEWMEDIAWIRE)-ABVC BioPharma, Inc.(...<BR><a href="observerbio/post/1381958483" target="_blank">...繼續閱讀</a> <![CDATA[生醫材料廣泛應用成產業新寵,加拿大生技商OncoX專利Lycogen可治療潰瘍兼提升經濟動物產能]]> observerbio/post/1381958480 observerbio/post/1381958480 Thu, 03 Apr 2025 18:12:23 +0800 observerbio/post/1381958480#reply <img src="//mypaper.pchome.com.tw/show/article/observerbio/A1381958480"><BR>原文連結:https://vocus.cc/article/677f98c0fd897800018d64e...<BR><a href="observerbio/post/1381958480" target="_blank">...繼續閱讀</a> ubao snddm index pchome yahoo rakuten mypaper meadowduck bidyahoo youbao zxmzxm asda bnvcg cvbfg dfscv mmhjk xxddc yybgb zznbn ccubao uaitu acv GXCV ET GDG YH FG BCVB FJFH CBRE CBC GDG ET54 WRWR RWER WREW WRWER RWER SDG EW SF DSFSF fbbs ubao fhd dfg ewr dg df ewwr ewwr et ruyut utut dfg fgd gdfgt etg dfgt dfgd ert4 gd fgg wr 235 wer3 we vsdf sdf gdf ert xcv sdf rwer hfd dfg cvb rwf afb dfh jgh bmn lgh rty gfds cxv xcv xcs vdas fdf fgd cv sdf tert sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf shasha9178 shasha9178 shasha9178 shasha9178 shasha9178 liflif2 liflif2 liflif2 liflif2 liflif2 liblib3 liblib3 liblib3 liblib3 liblib3 zhazha444 zhazha444 zhazha444 zhazha444 zhazha444 dende5 dende denden denden2 denden21 fenfen9 fenf619 fen619 fenfe9 fe619 sdf sdf sdf sdf sdf zhazh90 zhazh0 zhaa50 zha90 zh590 zho zhoz zhozh zhozho zhozho2 lislis lls95 lili95 lils5 liss9 sdf0ty987 sdft876 sdft9876 sdf09876 sd0t9876 sdf0ty98 sdf0976 sdf0ty986 sdf0ty96 sdf0t76 sdf0876 df0ty98 sf0t876 sd0ty76 sdy76 sdf76 sdf0t76 sdf0ty9 sdf0ty98 sdf0ty987 sdf0ty98 sdf6676 sdf876 sd876 sd876 sdf6 sdf6 sdf9876 sdf0t sdf06 sdf0ty9776 sdf0ty9776 sdf0ty76 sdf8876 sdf0t sd6 sdf06 s688876 sd688 sdf86